GLS and neoplasm: Inhibition of GLUL in CAFs, together with GLS inhibition in cancer cells, led to a synergistic effect in reducing tumour weight and metastasis in ovarian cancer mouse models when compared to monotherapy by disrupting the metabolic crosstalk between CAFs and ovarian tumour cells [79].